DR. STEVEN LEHRER, M.D.
Medical Practice at 60 St, New York, NY

License number
New York 106513
Category
Medical Practice
Type
Specialist
Address
Address
30 W 60Th St, New York, NY 10023
Phone
(212) 765-7132
(212) 245-9708 (Fax)
National Provider ID: 1568500163
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about STEVEN LEHRER at radaris.com
Name
Address
Phone
Steven Lehrer, age 70
100 Ursula Dr, Roslyn, NY 11576
Steven Lehrer
5 2Nd Rd, Great Neck, NY 11021
Steven Lehrer, age 80
30 W 60Th St APT 9T, New York, NY 10023
(212) 765-7132
Steven Lehrer
194 N Clinton Ave, Bay Shore, NY 11706
(631) 379-2910
Steven M Lehrer, age 72
194 Clinton Ave, Bay Shore, NY 11706
(631) 968-0577
(631) 968-5837

Organization information

See more information about STEVEN LEHRER at bizstanding.com

Steven Lehrer MD

30 W 60 St, New York, NY 10023

Industry:
Radiology
Phone:
(212) 765-7132 (Phone)
Steven Phillip Lehrer

Professional information

Steven Lehrer Photo 1

Compositions And Methods Of Treating And Preventing Lung Cancer And Lymphangioleiomyomatosis

US Patent:
2013000, Jan 3, 2013
Filed:
Sep 12, 2012
Appl. No.:
13/611894
Inventors:
Steven Lehrer - New York NY, US
International Classification:
A61K 31/155, A61K 38/20, A61N 5/10, A61P 35/04, A61P 11/00, A61K 38/21, A61P 35/00
US Classification:
424 45, 514635, 424 43, 424 854, 424 852, 600 1
Abstract:
Compositions and methods for treating and preventing cancer, particularly lung cancer, lymphangioleiomyomatosis and asthma are provided.

Steven Lehrer Photo 2

Independent Pharmaceuticals Professional
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Education:
The Johns Hopkins University School of Medicine

Steven Lehrer Photo 3

Compositions And Methods Of Treating And Preventing Lung Cancer

US Patent:
2011022, Sep 22, 2011
Filed:
Mar 15, 2011
Appl. No.:
13/048541
Inventors:
Steven Lehrer - New York NY, US
International Classification:
A61K 31/155, A61K 9/12, A61P 35/00, A61P 3/10
US Classification:
424 45, 514635, 424 43
Abstract:
Compositions and methods for treating and preventing cancer, particularly lung cancer, are provided.

Steven Lehrer Photo 4

Optician At Cove Opticians
Position:
Optician at Cove Opticians
Location:
Greater New York City Area
Industry:
Consumer Services
Work:
Cove Opticians - Optician

Steven P Lehrer Photo 5

Dr. Steven P Lehrer, New York NY - MD (Doctor of Medicine)
Specialties:
Radiology, Nuclear Medicine
Address:
30 W 60Th St, New York 10023
(212) 765-7132 (Phone), (212) 245-9708 (Fax)
Certifications:
Nuclear Medicine, 1974, Radiology
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1969
St Lukes-Roosevelt Hospital Center At Roosevelt Division
Jewish Hosp-Med Ctr
SUNY Downstate Med Ctr

Steven Lehrer Photo 6

Method For Detecting Prostate Cancer By Apolipoprotein E (Apo-E) Genotyping

US Patent:
5945289, Aug 31, 1999
Filed:
Dec 19, 1997
Appl. No.:
8/995083
Inventors:
Steven Lehrer - New York NY
International Classification:
C12Q 168, C12P 1934
US Classification:
435 6
Abstract:
Methods for assessing a patient's predisposition for developing prostate cancer are disclosed. PCR assays using primers for apolipoprotein E (ApoE) genotypes and primers for known prostate cancer molecular markers such as PSA are applied to biological samples. ApoE4/E4 homozygosity coupled with elevated PSA or other prostate cancer marker levels in the blood, indicate the likelihood that prostate cancer is present.

Steven Lehrer Photo 7

Methods And Compositions For The Treatment Of Cancer

US Patent:
2008011, May 22, 2008
Filed:
Nov 16, 2006
Appl. No.:
11/600572
Inventors:
Steven Lehrer - New York NY, US
International Classification:
A61K 31/566, A61P 35/00, A61K 31/4015, A61K 31/351, A61K 31/21, A61K 31/4965, A61K 31/47, A61K 31/404, A61K 31/4196
US Classification:
514171, 514383, 514423, 514415, 514460, 514311, 514529, 514275
Abstract:
The present invention provides methods to treat neoplastic disorders in a human comprising the use of aromatase inhibitors and HMG-CoA reductase inhibitors (statins).

Medical Practice licenses in New York










Other Doctors licenses in New York